Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.33
-0.13 (-1.37%)
At close: Jun 27, 2025, 4:00 PM
9.40
+0.07 (0.75%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $719.22 million as of June 27, 2025. Its market cap has increased by 30.12% in one year.
Market Cap
719.22M
Enterprise Value
311.58M
1-Year Change
30.12%
Ranking
Category
Stock Price
$9.33
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $719.22M, an increase of 53.84%. That is a compound annual growth rate of 6.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.60B |
| Johnson & Johnson | 365.53B |
| AbbVie | 329.79B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.68B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.62B |
| AstraZeneca | 216.45B |